Optimal Management of Primary Breast Cancer (Q34248600)

31 July 2017

title

Optimal Management of Primary Breast Cancer (English)

1 reference

31 July 2017

Atilla Soran

1

1 reference

31 July 2017

Victor G. Vogel

series ordinal

2

1 reference

31 July 2017

publication date

1 March 1999

1 reference

31 July 2017

1 reference

31 July 2017

volume

5

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

81-93

1 reference

Estimates of the worldwide incidence of eighteen major cancers in 1985.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Intraductal carcinoma of the breast (208 cases). Clinical factors influencing treatment choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Follow-up of two treatment modalities for ductal cancer in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Duct carcinoma in situ: predictors of local recurrence and progression in patients treated by surgery alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Controversies in the treatment of ductal carcinoma in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Lobular carcinoma in situ of the breast. An approach to rational treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Lobular neoplasia of the breast: Higher risk for subsequent invasive cancer predicted by more extensive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

The Continuing Dilemma of Lobular Carcinoma In Situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Lobular carcinoma in situ: observation without surgery as an appropriate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Patient selection criteria for conservation surgery versus mastectomy: Memorial Hospital breast service experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Long-term results of breast conservation therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Radiotherapy after breast-preserving surgery in women with localized cancer of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Risk factors in breast-conservation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Factors associated with surgical and radiation therapy for early stage breast cancer in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Breast cancer in elderly women: presentation, survival, and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Adequate locoregional treatment for early breast cancer may prevent secondary dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Management of stage III breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Primary chemotherapy in surgically resectable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Primary chemotherapy for early and advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Breast cancer adjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Inflammatory carcinoma of the breast: results of a combined-modality approach--M.D. Anderson Cancer Center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Adjuvant systemic therapy for breast cancer in the elderly: competing causes of mortality. International Breast Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Local recurrences after breast conserving surgery and radiotherapy: correlation of histopathological risk factors with age

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

Induction Chemotherapy with Cisplatin, Doxorubicin, and Cyclophosphamide (CAP) in a Combined Modality Approach for Locally Advanced and Inflammatory Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.1999.00130.X

10.1046/J.1524-4741.1999.00130.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference